Hyperglycemic memory in diabetic cardiomyopathy
Open Access
- 18 December 2021
- journal article
- review article
- Published by Springer Nature in Frontiers of Medicine
- Vol. 16 (1) , 25-38
Abstract
Cardiovascular diseases account for approximately 80% of deaths among individuals with diabetes mellitus, with diabetic cardiomyopathy as the major diabetic cardiovascular complication. Hyperglycemia is a symptom that abnormally activates multiple downstream pathways and contributes to cardiac hypertrophy, fibrosis, apoptosis, and other pathophysiological changes. Although glycemic control has long been at the center of diabetes therapy, multicenter randomized clinical studies have revealed that intensive glycemic control fails to reduce heart failure-associated hospitalization and mortality in patients with diabetes. This finding indicates that hyperglycemic stress persists in the cardiovascular system of patients with diabetes even if blood glucose level is tightly controlled to the normal level. This process is now referred to as hyperglycemic memory (HGM) phenomenon. We briefly reviewed herein the current advances that have been achieved in research on the underlying mechanisms of HGM in diabetic cardiomyopathy.Keywords
This publication has 135 references indexed in Scilit:
- Reactive oxygen species-responsive miR-210 regulates proliferation and migration of adipose-derived stem cells via PTPN2Cell Death & Disease, 2013
- Inhibition of α-KG-dependent histone and DNA demethylases by fumarate and succinate that are accumulated in mutations of FH and SDH tumor suppressorsGenes & Development, 2012
- Diabetic cardiomyopathy: pathophysiology and clinical featuresHeart Failure Reviews, 2012
- O-GlcNAc cycling: Emerging roles in development and epigeneticsSeminars in Cell & Developmental Biology, 2010
- Epigenetic mechanisms in the development of type 2 diabetesTrends in Endocrinology & Metabolism, 2010
- In Vivo Residue-specific Histone Methylation DynamicsJournal of Biological Chemistry, 2010
- Retracted:Advanced glycation endproduct (AGE) accumulation and AGE receptor (RAGE) up‐regulation contribute to the onset of diabetic cardiomyopathyJournal of Cellular and Molecular Medicine, 2008
- Transient high glucose causes persistent epigenetic changes and altered gene expression during subsequent normoglycemiaJournal of Experimental Medicine, 2008
- Dysregulation of microRNAs after myocardial infarction reveals a role of miR-29 in cardiac fibrosisProceedings of the National Academy of Sciences, 2008
- Histone deacetylase inhibition reduces myocardial ischemia‐reperfusion injury in miceThe FASEB Journal, 2008